drugset / Trial / NCT05548387
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the pharmacokinetic characteristics and safety between HCP2202 and co-administration of each component in fasting condition in healthy volunteers.
Timeline
- Start
- 2022-09-02
- Primary completion
- 2022-11-10
- Completion
- 2022-11-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HCP2202 | Unknown | — | — |
| Subject | RLD2202 | Unknown | — | — |
| Subject | RLD2203 | Unknown | — | — |
Indications
No indication recorded.